PrEP HIV Baseline, Male Panel with Reflexes
Also known as: Truvada, PrEP Monitoring, Tenofovir, HIV Prevention, TDF/FTC
Use
This panel is intended to determine clinical eligibility for HIV pre‑exposure prophylaxis (PrEP) in male patients. It includes CDC guideline–recommended baseline testing components such as HIV‑1/2 antigen/antibody (4th generation), renal function (e.g., creatinine, eGFR), hepatitis B and C screening (HBV HBsAg, HBcAb, HBsAb; HCV antibody), syphilis (RPR with reflex to titer and confirmatory testing), and screening for chlamydia and gonorrhea via NAAT—thus allowing comprehensive evaluation prior to initiating PrEP.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Other
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Not provided.
Other tests from different labs that may be relevant